1 unknown. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
Follow Induction Therapy: new trials by email Literature Review of Induction Therapy trials Research Report on Induction Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimum Induction Therapy of Low-risk APL Etoposide, Daunorubicin - Acute Promyelocytic Leukemia, Induction Therapy | Not applicable | Unknown | Peking University People's Hospital | 74 | 2023-01-01 | 2024-05-10 |
Leukemia, Promyelocytic, Acute (1)
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Leukemia (1) · Leukemia, Myeloid (1) · Leukemia, Myeloid, Acute (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Daunorubicin (1) · Etoposide (1) · Tretinoin (1)
Peking University People's Hospital (1)
China (1)